open access articleStaphylococcus aureus biofilms are a significant problem in healthcare settings, in part, owing to the presence of a non-dividing, antibiotic tolerant sub-population. Here we evaluated treatment of S. aureus UAMS-1 biofilms with HT61, a quinoline derivative shown to be effective against non-dividing Staphylococcal spp. HT61 was effective in reducing biofilm viability, associated with increased expression of cell wall stress and division proteins, confirming its potential as a treatment for S. aureus biofilm infections
Staphylococcus aureus is a Gram-positive bacterium found frequently on a person’s skin and sometimes...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus biofilms are a significant problem in health care settings, partly due to the ...
Staphylococcus aureus biofilms are a significant problem in health care settings, partly due to the ...
Staphylococcus aureus is a major cause of nosocomial infections and secretes a diverse spectrum of v...
�� 2021 The Authors. Published by MDPI. This is an open access article available under a Creative Co...
Multidrug-resistant (MDR) bacterial infections are a top five global public health threat, causing 2...
Bacterial infections are becoming increasingly difficult to treat due to the emergence of antimicrob...
Bacteria can be found as surface adhered, structured colonies that generate an extracellular matrix,...
Taylor-Robinson, AW ORCiD: 0000-0001-7342-8348Staphylococcus aureus is a Gram-positive bacterium fou...
Abstract The quorum-sensing inhibitor RIP inhibits staphylococcal TRAP/agr systems and both TRAP- a...
Staphylococcus aureus is a nosocomial bacterium causing different infectious diseases, ranging from ...
Staphylococcus aureus is a Gram-positive bacterium found frequently on a person’s skin and sometimes...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus is a Gram-positive bacterium found frequently on a person’s skin and sometimes...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus biofilms are a significant problem in health care settings, partly due to the ...
Staphylococcus aureus biofilms are a significant problem in health care settings, partly due to the ...
Staphylococcus aureus is a major cause of nosocomial infections and secretes a diverse spectrum of v...
�� 2021 The Authors. Published by MDPI. This is an open access article available under a Creative Co...
Multidrug-resistant (MDR) bacterial infections are a top five global public health threat, causing 2...
Bacterial infections are becoming increasingly difficult to treat due to the emergence of antimicrob...
Bacteria can be found as surface adhered, structured colonies that generate an extracellular matrix,...
Taylor-Robinson, AW ORCiD: 0000-0001-7342-8348Staphylococcus aureus is a Gram-positive bacterium fou...
Abstract The quorum-sensing inhibitor RIP inhibits staphylococcal TRAP/agr systems and both TRAP- a...
Staphylococcus aureus is a nosocomial bacterium causing different infectious diseases, ranging from ...
Staphylococcus aureus is a Gram-positive bacterium found frequently on a person’s skin and sometimes...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus is a Gram-positive bacterium found frequently on a person’s skin and sometimes...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...